Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

The ability to compare the volumes of patients’ brain structures to brain structure volumes of healthy controls is a powerful tool to help physicians assess possible existence of neurodegeneration or the progression of a neurodegenerative disorder.

To adjust for any variation in brain size, sex difference, and inter-individual head-size in a population, brain structure volumes are normalized (or scaled) to a common measurement.

Cortechs.ai’ quantitative imaging software uses Intracranial Volume (ICV) to normalize an individual’s brain structure volumes, and automatically calculates it during the post-processing of brain MRIs for volumetric analysis. This consistent measure gives clinicians additional context of their patient’s brain structure volumes, regardless of head size.

ICV, also known as TIV (Total Intracranial Volume), is the volume of the cranial cavity as taken from a 3D T1 MRI, as outlined by the supratentorial dura matter, or cerebral contour when dura is not clearly detectable.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products
Example of segmentation with intracranial mask from T1-weighted image. Image credit: Malone, I.B. et al. (2015). Accurate Automatic Estimation of Total Intracranial Volume: A Nuisance Variable with Less Nuisance. NeuroImage 104 (366-372).

ICV is a very consistent measure across the lifespan of a patient, making it a reliable tool for correction of head size variation across individuals. This correction is especially helpful when assessing neurodegenerative conditions.

For example, Patient A and Patient B both have thalamic volumes that are consistent with the average for their age and sex-matched population. Patient A is 5’6” tall, with an average head circumference, while Patient B is 6’2” tall with an above average head circumference. If the thalamic volumes could be interpreted without correcting for ICV, both patients would yield a normal result. However, once the patient’s thalamic volumes are normalized to their individual ICV, it could become apparent that Patient B’s thalamic volume is lower than expected for their age and gender.

NeuroQuant reports provide brain structure volumes (relevant to the report), % ICV and normative percentiles. NeuroQuant automatically calculates the ICV to accurately compare an individual’s brain structure volumes to Cortechs.ai’ age and sex-matched normative reference data. The ICV normalization and reference comparison on NeuroQuant reports provide physicians with a framework to better understand brain structure volumes when assessing patients.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Need more information about ICV or Cortechs.ai quantitative image products? Contact us.

 

More Resources

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

11/17/2025

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Discover how Imaging Healthcare Specialists integrated OnQ™ Prostate to enhance lesion visibility, boost diagnostic confidence, and improve communication.

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision
Scroll to Top